Osiris Therapeutics Inc. (OSIR) has been rising for the majority of early trade Friday morning and is now up 1.02 at $9.09 on above average volume.
Osiris Therapeutics has climbed sharply in the last 3 sessions and is now trading at a new high for the year. The company announced Thursday that it received consent from New Zealand to market its stem cell therapy Prochymal, for the treatment of acute graft-vs.-host disease in children.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.